Valproic Acid Signature Trial (VAST): A proof-of-principle study correlating pharmacology, pathology, and advanced imaging with genomic prediction of drug sensitivity in breast cancer.
A. L. Cohen
No relevant relationships to disclose
M. Schabel
No relevant relationships to disclose
A. Bild
No relevant relationships to disclose
T. L. Werner
No relevant relationships to disclose